CENTENE CORPORATION Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest
CENTENE CORPORATION (CNC) reported Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest of $1.09 billion for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Shareholders' Equity
us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest · last filed 2026-07-28
- CENTENE CORPORATION net income (loss), including portion attributable to nonredeemable noncontrolling interest for the quarter ending 2026-06-30 was $1.09B.
- CENTENE CORPORATION net income (loss), including portion attributable to nonredeemable noncontrolling interest for the quarter ending 2026-03-31 was $1.54B, a 17.15% increase year-over-year.
- CENTENE CORPORATION net income (loss), including portion attributable to nonredeemable noncontrolling interest for the quarter ending 2025-09-30 was -$6.63B, a 1031.60% decline year-over-year.
- CENTENE CORPORATION net income (loss), including portion attributable to nonredeemable noncontrolling interest for the quarter ending 2025-06-30 was -$258.00M, a 122.51% decline year-over-year.
- CENTENE CORPORATION net income (loss), including portion attributable to nonredeemable noncontrolling interest for fiscal 2025 was -$6.68B, a 302.42% decline from fiscal 2024.
- CENTENE CORPORATION net income (loss), including portion attributable to nonredeemable noncontrolling interest for fiscal 2024 was $3.30B, a 22.27% increase from fiscal 2023.
- CENTENE CORPORATION net income (loss), including portion attributable to nonredeemable noncontrolling interest for fiscal 2023 was $2.70B, a 127.00% increase from fiscal 2022.
- CENTENE CORPORATION net income (loss), including portion attributable to nonredeemable noncontrolling interest for fiscal 2022 was $1.19B, a 10.33% decline from fiscal 2021.
| Period end | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 9 month | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.09B 10-Q · filed 2026-07-28 | $2.63B derived: sum of 2 quarters · filed 2026-07-28 | ||
| 2026-03-31 | $1.54B 10-Q · filed 2026-07-28 | |||
| 2025-12-31 | -$6.68B 10-K · filed 2026-02-17 | |||
| 2025-09-30 | -$6.63B 10-Q · filed 2025-10-29 | -$6.89B derived: sum of 2 quarters · filed 2026-07-28 | -$5.58B derived: sum of 3 quarters · filed 2026-07-28 | |
| 2025-06-30 | -$258.00M 10-Q · filed 2026-07-28 | $1.05B derived: sum of 2 quarters · filed 2026-07-28 | ||
| 2025-03-31 | $1.31B 10-Q · filed 2026-07-28 | |||
| 2024-12-31 | $3.30B 10-K · filed 2026-02-17 | |||
| 2024-09-30 | $712.00M 10-Q · filed 2025-10-29 | $1.86B derived: sum of 2 quarters · filed 2025-10-29 | $3.02B derived: sum of 3 quarters · filed 2025-10-29 | |
| 2024-06-30 | $1.15B 10-Q · filed 2025-10-29 | $2.31B derived: sum of 2 quarters · filed 2025-10-29 | ||
| 2024-03-31 | $1.16B 10-Q · filed 2025-10-29 | |||
| 2023-12-31 | $2.70B 10-K · filed 2026-02-17 | |||
| 2023-09-30 | $472.00M 10-Q · filed 2024-10-25 | $1.53B derived: sum of 2 quarters · filed 2024-10-25 | $2.66B derived: sum of 3 quarters · filed 2024-10-25 | |
| 2023-06-30 | $1.05B 10-Q · filed 2024-10-25 | $2.19B derived: sum of 2 quarters · filed 2024-10-25 | ||
| 2023-03-31 | $1.13B 10-Q · filed 2024-10-25 | |||
| 2022-12-31 | $1.19B 10-K · filed 2025-02-18 | |||
| 2022-09-30 | $736.00M 10-Q · filed 2023-10-24 | $561.00M derived: sum of 2 quarters · filed 2023-10-24 | $1.41B derived: sum of 3 quarters · filed 2023-10-24 | |
| 2022-06-30 | -$175.00M 10-Q · filed 2023-10-24 | $673.00M derived: sum of 2 quarters · filed 2023-10-24 | ||
| 2022-03-31 | $848.00M 10-Q · filed 2023-10-24 | |||
| 2021-12-31 | $1.33B 10-K · filed 2024-02-20 | |||
| 2021-09-30 | $576.00M 10-Q · filed 2022-10-25 | $38.00M derived: sum of 2 quarters · filed 2022-10-25 | $732.00M derived: sum of 3 quarters · filed 2022-10-25 | |
| 2021-06-30 | -$538.00M 10-Q · filed 2022-10-25 | $156.00M derived: sum of 2 quarters · filed 2022-10-25 | ||
| 2021-03-31 | $694.00M 10-Q · filed 2022-10-25 | |||
| 2020-12-31 | $1.78B 10-K · filed 2023-02-21 | |||
| 2020-09-30 | $562.00M 10-Q · filed 2021-10-26 | $1.76B derived: sum of 2 quarters · filed 2021-10-26 | $1.80B derived: sum of 3 quarters · filed 2021-10-26 | |
| 2020-06-30 | $1.20B 10-Q · filed 2021-10-26 | $1.24B derived: sum of 2 quarters · filed 2021-10-26 | ||
| 2020-03-31 | $43.00M 10-Q · filed 2021-10-26 | |||
| 2019-12-31 | $1.31B 10-K · filed 2022-02-22 | |||
| 2019-09-30 | $95.00M 10-Q · filed 2020-10-27 | $590.00M derived: sum of 2 quarters · filed 2020-10-27 | $1.11B derived: sum of 3 quarters · filed 2020-10-27 | $1.35B derived: sum of 4 quarters · filed 2021-02-22 |
| 2019-06-30 | $495.00M 10-Q · filed 2020-10-27 | $1.01B derived: sum of 2 quarters · filed 2020-10-27 | $1.26B derived: sum of 3 quarters · filed 2021-02-22 | $1.27B derived: sum of 4 quarters · filed 2021-02-22 |
| 2019-03-31 | $520.00M 10-Q · filed 2020-10-27 | $762.00M derived: sum of 2 quarters · filed 2021-02-22 | $777.00M derived: sum of 3 quarters · filed 2021-02-22 | $1.08B derived: sum of 4 quarters · filed 2021-02-22 |
| 2018-12-31 | $242.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-22 | $257.00M derived: sum of 2 quarters · filed 2021-02-22 | $557.00M derived: sum of 3 quarters · filed 2021-02-22 | $898.00M 10-K · filed 2021-02-22 |
| 2018-09-30 | $15.00M 10-Q · filed 2019-10-22 | $315.00M derived: sum of 2 quarters · filed 2019-10-22 | $656.00M 10-Q · filed 2018-10-23 | $887.00M derived: sum of 4 quarters · filed 2020-02-18 |
| 2018-06-30 | $300.00M 10-Q · filed 2019-10-22 | $641.00M 10-Q · filed 2018-07-24 | $872.00M derived: sum of 3 quarters · filed 2020-02-18 | $1.08B derived: sum of 4 quarters · filed 2020-02-18 |
| 2018-03-31 | $341.00M 10-Q · filed 2019-10-22 | $572.00M derived: sum of 2 quarters · filed 2020-02-18 | $776.00M derived: sum of 3 quarters · filed 2020-02-18 | $1.03B derived: sum of 4 quarters · filed 2020-02-18 |
| 2017-12-31 | $231.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-18 | $435.00M derived: sum of 2 quarters · filed 2020-02-18 | $689.00M derived: sum of 3 quarters · filed 2020-02-18 | $828.00M 10-K · filed 2020-02-18 |
| 2017-09-30 | $204.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-24 | $458.00M derived: sum of 2 quarters · filed 2017-10-24 | $597.00M 10-Q · filed 2017-10-24 | $863.00M derived: sum of 4 quarters · filed 2019-02-19 |
| 2017-06-30 | $254.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-25 | $393.00M 10-Q · filed 2017-07-25 | $659.00M derived: sum of 3 quarters · filed 2019-02-19 | $804.00M derived: sum of 4 quarters · filed 2019-02-19 |
| 2017-03-31 | $139.00M 10-Q · filed 2017-04-25 | $405.00M derived: sum of 2 quarters · filed 2019-02-19 | $550.00M derived: sum of 3 quarters · filed 2019-02-19 | $718.00M derived: sum of 4 quarters · filed 2019-02-19 |
| 2016-12-31 | $266.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-19 | $411.00M derived: sum of 2 quarters · filed 2019-02-19 | $579.00M derived: sum of 3 quarters · filed 2019-02-19 | $563.00M 10-K · filed 2019-02-19 |
| 2016-09-30 | $145.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-25 | $313.00M derived: sum of 2 quarters · filed 2016-10-25 | $297.00M 10-Q · filed 2016-10-25 | $408.00M derived: sum of 4 quarters · filed 2018-02-20 |
| 2016-06-30 | $168.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-26 | $152.00M 10-Q · filed 2016-07-26 | $263.00M derived: sum of 3 quarters · filed 2018-02-20 | $356.00M derived: sum of 4 quarters · filed 2018-02-20 |
| 2016-03-31 | -$16.00M 10-Q · filed 2016-04-26 | $95.00M derived: sum of 2 quarters · filed 2018-02-20 | $188.00M derived: sum of 3 quarters · filed 2018-02-20 | $276.00M derived: sum of 4 quarters · filed 2018-02-20 |
| 2015-12-31 | $111.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-20 | $204.00M derived: sum of 2 quarters · filed 2018-02-20 | $292.00M derived: sum of 3 quarters · filed 2018-02-20 | $355.00M 10-K · filed 2018-02-20 |
| 2015-09-30 | $93.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-27 | $181.00M derived: sum of 2 quarters · filed 2015-10-27 | $244.00M 10-Q · filed 2015-10-27 | |
| 2015-06-30 | $88.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-28 | $151.00M 10-Q · filed 2015-07-28 | ||
| 2015-03-31 | $63.00M 10-Q · filed 2015-04-28 | |||
| 2014-12-31 | $270.00M 10-K · filed 2017-02-21 | |||
| 2013-12-31 | $166.00M 10-K · filed 2016-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HUMANA INC (HUM) | United States | $45.651B | 18.44 |
| MOLINA HEALTHCARE, INC. (MOH) | United States | $10.091B | -1,697.50 |
| Alignment Healthcare, Inc. (ALHC) | United States | $1.593B | 121.28 |
| TRUPANION, INC. (TRUP) | United States | $0.984B | |
| Cigna Group (CI) | United States | $70.160B | 10.44 |
| Elevance Health, Inc. (ELV) | United States | $86.364B | 16.90 |
| UNITEDHEALTH GROUP INC (UNH) | United States | $336.652B | 26.62 |